Dr Charles Haworth,

MD FRCP

Consultant Respiratory Physician, Cambridge Centre for Lung Infection

Charles Haworth is a respiratory consultant working within the Cambridge Centre for Lung Infection at Royal Papworth Hospital. He is also an honorary consultant at Addenbrooke’s Hospital in Cambridge.

 

The Adult Cystic Fibrosis (CF) Centre oversees the care of >330 adults with CF. The Lung Defence Clinic oversees the care of >2000 patients with bronchiectasis associated with primary and secondary immunodeficiencies, non-tuberculous mycobacterial (NTM) lung disease, Aspergillus-related lung disease, rheumatoid arthritis, serious childhood infection, chronic aspiration and primary ciliary dyskinesia. Both the Adult Cystic Fibrosis Centre and Lung Defence Clinic have European Reference Network (ERN) designation.

 

Dr Haworth trained at the Manchester Adult Cystic Fibrosis Centre, Hammersmith Hospital and the Royal Brompton Hospital before moving to Cambridge in 2003.

 

He is the senior author of the US Cystic Fibrosis Foundation & European Cystic Fibrosis Society (ECFS) NTM guidelines published in 2016 and is first author of the British Thoracic Society (BTS) NTM guidelines published in 2017. He also co-authored the European Respiratory Society Bronchiectasis guidelines published in September 2017 and is a member of the BTS Bronchiectasis guidelines committee.

 

Dr Haworth is an Honorary Visiting Senior Fellow in the Department of Medicine at the University of Cambridge; he is a member of two European Union Framework Programme 7 funded  research consortia (iABC and CFMATTERS); he is co-chief investigator of international multicentre novel therapy clinical trials in people with bronchiectasis; he is the Papworth site Principal Investigator for the ECFS Clinical Trials network; he is a member of the US Cystic Fibrosis Foundation Data Safety Monitoring Board; he is a Steering Committee and Scientific Committee member of the European Bronchiectasis Registry (EMBARC); he is a member of the Cystic Fibrosis Trust Strategic Implementation Board; and a founding member of the UK Cystic Fibrosis Medical Association.